Jacobs Levy Equity Management’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-506,815
| Closed | -$1.34M | – | 958 |
|
|
2024
Q2 | $1.34M | Buy |
506,815
+9,340
| +2% | +$24.8K | 0.01% | 675 |
|
|
2024
Q1 | $1.36M | Buy |
497,475
+227,278
| +84% | +$623K | 0.01% | 659 |
|
|
2023
Q4 | $657K | Sell |
270,197
-29,464
| -10% | -$71.6K | ﹤0.01% | 787 |
|
|
2023
Q3 | $605K | Buy |
299,661
+98,912
| +49% | +$200K | ﹤0.01% | 764 |
|
|
2023
Q2 | $592K | Sell |
200,749
-20,329
| -9% | -$60K | ﹤0.01% | 790 |
|
|
2023
Q1 | $553K | Sell |
221,078
-31,619
| -13% | -$79K | ﹤0.01% | 791 |
|
|
2022
Q4 | $801K | Buy |
252,697
+762
| +0.3% | +$2.42K | 0.01% | 712 |
|
|
2022
Q3 | $748K | Buy |
+251,935
| New | +$748K | 0.01% | 768 |
|